有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[(1R)-1-(4-chlorophenyl)sulfanylethyl]-5-thiophen-2-yl-1,3,4-oxadiazole | —— | C14H11ClN2OS2 |
|
—— | 3-[(1R)-1-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)ethyl]sulfanyl-1H-1,2,4-triazol-5-amine | —— | C10H10N6OS2 |
|
—— | N-[(1R)-1-(1-adamantyl)ethyl]-2-[[5-(butylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C20H32N4OS2 |
|
—— | N-(2-methylphenyl)-5-prop-2-enylsulfanyl-1,3,4-thiadiazol-2-amine | —— | C12H13N3S2 |
|
—— | 5-[(1-butyltetrazol-5-yl)methylsulfanyl]-N-(3,4-dimethylphenyl)-1,3,4-thiadiazol-2-amine | —— | C16H21N7S2 |
|
—— | N-(2-methylphenyl)-5-[(1S)-1-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)ethyl]sulfanyl-1,3,4-thiadiazol-2-amine | —— | C17H15N5OS3 |
|
—— | N-(2-cyanoethyl)-N-methyl-2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C15H17N5OS2 |
|
—— | N-(2-methylphenyl)-5-[(1R)-1-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)ethyl]sulfanyl-1,3,4-thiadiazol-2-amine | —— | C17H15N5OS3 |
|
—— | N-(3-methylphenyl)-5-[(1S)-1-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)ethyl]sulfanyl-1,3,4-thiadiazol-2-amine | —— | C17H15N5OS3 |
|
—— | N-(cyclopenten-1-yl)-2-[[5-[4-(diethylamino)phenyl]-1,3,4-oxadiazol-2-yl]sulfanyl]-N-ethylacetamide | —— | C21H28N4O2S |
|
—— | 3-[4,6-dimethyl-2-(methylsulfanyl)pyrimidin-5-yl]-N-[(4-fluorophenyl)methyl]propanamide | —— | C17H20FN3OS |
|
—— | (2R)-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]propanamide | —— | C20H21FN4OS2 |
|
—— | (2S)-2-[[5-(2-fluoroanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-(methylcarbamoyl)propanamide | —— | C13H14FN5O2S2 |
|
—— | N-[(1S)-1-cyano-1-cyclopropylethyl]-2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetamide | —— | C17H19N5OS2 |
|
—— | N-(cyclopropylmethyl)-2-[[5-(2,3-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-N-propylacetamide | —— | C19H26N4OS2 |
|
—— | 3-(2-Piperidin-1-ium-1-ylethylsulfanyl)-1-piperidin-1-yl-5,6,7,8-tetrahydroisoquinolin-2-ium-4-carbonitrile | —— | C22H34N4S+2 |
|
—— | methyl (2S)-2-[(4-cyano-1-morpholin-4-yl-5,6,7,8-tetrahydroisoquinolin-3-yl)sulfanyl]butanoate | —— | C19H25N3O3S |
|
—— | 3-{[3-(Dimethylamino)propyl]sulfanyl}-1-(piperidin-1-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile | —— | C20H30N4S |
|
—— | 3-[(4-Cyano-1-piperidin-1-yl-5,6,7,8-tetrahydroisoquinolin-2-ium-3-yl)sulfanyl]propyl-dimethylazanium | —— | C20H32N4S+2 |
|
—— | 3-{[2-(Dimethylamino)ethyl]sulfanyl}-1-(piperidin-1-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile | —— | C19H28N4S |
|
—— | 3-{[3-(Dimethylamino)propyl]sulfanyl}-1-(morpholin-4-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile | —— | C19H28N4OS |
|
—— | 4-Methyl-6-(2-morpholin-4-ium-4-ylethylsulfanyl)-2-phenylpyrimidine-5-carbonitrile | —— | C18H21N4OS+ |
|
—— | 3-[(4-Cyano-1-morpholin-4-yl-5,6,7,8-tetrahydroisoquinolin-2-ium-3-yl)sulfanyl]propyl-dimethylazanium | —— | C19H30N4OS+2 |
|
—— | 1-(4-Methylpiperidin-1-yl)-3-{[2-(pyrrolidin-1-yl)ethyl]sulfanyl}-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile | —— | C22H32N4S |
|
—— | 1-(Piperidin-1-yl)-3-{[2-(pyrrolidin-1-yl)ethyl]sulfanyl}-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile | —— | C21H30N4S |
|
—— | 3-{[2-(Morpholin-4-yl)-2-oxoethyl]sulfanyl}-1-(piperidin-1-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile | —— | C21H28N4O2S |
|
—— | 2-[(4-Cyano-1-piperidin-1-yl-5,6,7,8-tetrahydroisoquinolin-2-ium-3-yl)sulfanyl]acetamide | —— | C17H23N4OS+ |
|
—— | [5-(4-Bromophenyl)furan-2-yl]methyl-[3-(1-methyltetrazol-5-yl)sulfanylpropyl]azanium | —— | C16H19BrN5OS+ |
|
—— | 2-[(4-Cyano-1-pyrrolidin-1-yl-5,6,7,8-tetrahydroisoquinolin-2-ium-3-yl)sulfanyl]ethyl-dimethylazanium | —— | C18H28N4S+2 |
|
—— | 3-[(4-Fluorobenzyl)sulfanyl]-1-(morpholin-4-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile | —— | C21H22FN3OS |
|
—— | 3-[[5-(3-Bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propanoate | —— | C11H8BrN2O3S- |
|
—— | 2-[[5-(2-Methylfuran-3-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetate | —— | C9H7N2O4S- |
|
—— | 2-[4-[(5-Amino-1,3,4-thiadiazol-2-yl)sulfanylmethyl]phenyl]acetic acid | —— | C11H11N3O2S2 |
|
—— | 2-[[5-(5-methylthiophen-3-yl)-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C14H18N4O2S2 |
|
—— | ethyl 2-[[5-ethyl-4-[[(2S)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]sulfanyl]acetate | —— | C13H21N3O3S |
|
—— | 2-Phenylsulfanyl-1-(4-prop-2-enylpiperazin-4-ium-1-yl)ethanone | —— | C15H21N2OS+ |
|
—— | 1-(4-Morpholinyl)-3-{[2-(4-morpholinyl)-2-oxoethyl]sulfanyl}-5,6,7,8-tetrahydro-4-isoquinolinecarbonitrile | —— | C20H26N4O3S |
|
—— | 3-[(4-Chlorobenzyl)sulfanyl]-1-(morpholin-4-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile | —— | C21H22ClN3OS |
|
—— | 3-[(2-Hydroxyethyl)sulfanyl]-1-(pyrrolidin-1-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile | —— | C16H21N3OS |
|
—— | 6-Methyl-3-(pentylsulfanyl)[1,2,4]triazino[5,6-d][3,1]benzoxazepine | —— | C16H18N4OS |
|
—— | 3-(2-Methoxyethylsulfanyl)-1-pyrrolidin-1-yl-5,6,7,8-tetrahydroisoquinolin-2-ium-4-carbonitrile | —— | C17H24N3OS+ |
|
—— | 3-[(4-Chlorophenyl)methylsulfanyl]-1-morpholin-4-yl-5,6,7,8-tetrahydroisoquinolin-2-ium-4-carbonitrile | —— | C21H23ClN3OS+ |
|
—— | N-butyl-N-[(2-methylphenyl)methyl]-2-pyridin-4-ylsulfanylacetamide | —— | C19H24N2OS |
|
—— | 2-[[4-methyl-5-(3-methylbutyl)-6-oxo-1H-pyrimidin-2-yl]sulfanyl]acetate | —— | C12H17N2O3S- |
|
—— | (2R)-N-(2-morpholin-4-ylethyl)-2-phenylsulfanylpropanamide | —— | C15H22N2O2S |
|
—— | (2S)-N-(2-morpholin-4-ium-4-ylethyl)-2-phenylsulfanylpropanamide | —— | C15H23N2O2S+ |
|
—— | N-[(Z)-(1-benzyl-3,5-dimethylpyrazol-4-yl)methylideneamino]-2-(2-fluorophenyl)sulfanylacetamide | —— | C21H21FN4OS |
|
—— | N-(2-phenylethyl)-2-pyridin-4-ylsulfanyl-N-(1,3-thiazol-2-ylmethyl)acetamide | —— | C19H19N3OS2 |
|
—— | N-[(Z)-(2,5-dimethylphenyl)methylideneamino]-2-(2-fluorophenyl)sulfanylacetamide | —— | C17H17FN2OS |
|
—— | (1S)-1-(3-fluoro-4-methylsulfanylphenyl)-N-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylmethyl)ethanamine | —— | C17H23FN4S |
|